May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?
dc.authorid | Aydin, Sukru/0000-0003-1105-3338 | |
dc.authorwosid | Aydin, Sukru/AAM-3613-2021 | |
dc.contributor.author | Aydin, Sukru | |
dc.contributor.author | Benk, Isilay Gokce | |
dc.contributor.author | Geckil, Aysegul Altintop | |
dc.date.accessioned | 2024-08-04T20:59:56Z | |
dc.date.available | 2024-08-04T20:59:56Z | |
dc.date.issued | 2021 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Objective: This study aimed to investigate the prognostic value of viral load detected in the saliva of COVID-19 patients in the early stage of infection. Study design: Oro-nasopharyngeal swab and saliva samples were collected from all patients simultaneously in the early stage of COVID-19. Viral loads were determined by extracting viral RNAs from saliva samples of patients whose ONP swabs were positive for SARS-CoV-2 by RT-qPCR. The demographic information, comorbidities, cycle threshold values, and one-month clinical courses were recorded and compared. Results: The patients' clinical course was evaluated for one month; 56 % of patients had mild disease, 26.4 % had moderate disease, 9.6 % had severe disease, and 8% had a critical/mortal disease. The average cycle threshold values of SARS-CoV-2 in saliva and ONP samples were measured as 22.28 and 24.19, respectively. Cycle threshold value of saliva was found to be significant in predicting disease severity (Eta coefficient 0.979). A statistically significant relationship was found between the disease's severity and the mean of ONP samples' Ctvalues (p < 0.05). Gender, age, body mass index, and co-morbidities were compared with the severity of the disease; no statistically significant difference was found. Conclusion: Viral load detected in saliva in the early period of COVID-19 infection may have a prognostic value in showing the disease's course in patients over 45-year-old. Saliva is an easily obtainable, reliable material for COVID-19 screening. | en_US |
dc.identifier.doi | 10.1016/j.jviromet.2021.114198 | |
dc.identifier.issn | 0166-0934 | |
dc.identifier.issn | 1879-0984 | |
dc.identifier.pmid | 34044003 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.jviromet.2021.114198 | |
dc.identifier.uri | https://hdl.handle.net/11616/103668 | |
dc.identifier.volume | 294 | en_US |
dc.identifier.wos | WOS:000661415300011 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Journal of Virological Methods | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.subject | Viral load | en_US |
dc.subject | Saliva | en_US |
dc.subject | Prognosis | en_US |
dc.title | May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients? | en_US |
dc.type | Article | en_US |